FDA Approves ColoSense, a Noninvasive mt-sRNA Test, for Adults 45 or Older
Geneoscopy’s ColoSense received FDA approval on May 06, 2024 based on data from the phase 3 CRC-PREVENT trial.
Geneoscopy’s ColoSense received FDA approval on May 06, 2024 based on data from the phase 3 CRC-PREVENT trial.
This cross-sectional study assesses the accuracy, sensitivity, and specificity of a large language model used to process unstructured, non-English emergency department (ED) data in medical…
“Adoption of this alloy will lead to more sustainable aviation and space exploration.”
Because the device is non-invasive, it’s a simple addition to physical rehabilitation programs—a sort of pilates for the fingers, explained the team.
The U.S. Food and Drug Administration approved on Tuesday Amgen’s Bkemv, the first biosimilar to AstraZeneca’s rare blood disorder treatment Soliris.
Google hopes a fresh injection of AI elements will make its ChromeOS platform even more enticing. But it’s not what sets Chromebook Plus systems apart.
A subsidiary of Colombian conglomerate Grupo Sura said on Tuesday it has asked for regulatory permission to dismantle its health business, in the latest blow…
For too long, the tools serving digital project management have simply failed industries like construction and manufacturing. Let’s look at a path forward for onsite…
This diagnostic study examines whether the neonatal lung ultrasonography score has equivalent accuracy to predict surfactant need in neonates born late preterm and later as…
Current strategies to protect children from malaria—administration of new RTS,S/AS01 or R21/Matrix-M vaccines as well as seasonal medications—require about 20 health care visits by the…
Neurocrine Biosciences CEO Kevin Gorman will retire on Oct. 11 after three decades with the company that he founded and will be succeeded by insider…